Biolojic Design
Human Antibody Therapeutics
StartupBiolojic Design is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2010. Human Antibody Therapeutics. The company has raised a total of $3.95M across 3 funding rounds, currently at the Seed stage. Biolojic Design was founded by Yanay Ofran, Prof. and Avi Molcho. Key investors include Western Technology Investment, OurCrowd, aMoon Fund, among 4 total investors. The company has 51-200 employees. Core technologies: Biologicals, Molecules, Artificial Intelligence, Machine Learning.
With $3.95M in total funding, Biolojic Design is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageSeed
- ProductReleased
- ModelB2B
- Employees51-200
- HQRehovot
- DistrictCenter District
- Last Round$7.5M
- Western Technology Investment
- OurCrowd
- aMoon Fund
4 investors total
Yanay Ofran, Prof.Founder & CEO
Avi MolchoCo-founder (No longer with the company)
11 articles covered by sources including www.calcalistech.com,
en.globes.co.il,
www.prnewswire.com,
www.genengnews.com,
www.haaretz.com.
What does Biolojic Design do?
Biolojic Design is a biopharmaceutical company dedicated to the development of human antibody-based therapeutics for cancer and other diseases. Biolojic Design has developed a new tool to re-engineer antibodies to bind new epitopes in a process known as re-epitoping. This technology has been shown to yield functional antibodies in difficult targets. Using proprietary algorithms, the company identifies an existing antibody that can be re-epitoped to bind the desired target. The antibody template is then engineered in an iterative computational and experimental approach to bind the desired epitope with high affinity. In 2014, Biolojic partnered with AstraZeneca's MedImmune LLC Biologics unit to discover antibodies for undisclosed targets selected by MedImmune, using Biolojic's computational and biochemical tools.
How much funding has Biolojic Design raised?
Biolojic Design has raised $3.95M in total funding across 3 rounds. The company is currently at the Seed stage. Key investors include Western Technology Investment, OurCrowd, aMoon Fund.
Who founded Biolojic Design?
Biolojic Design was founded in 2010 by Yanay Ofran, Prof. (Founder & CEO), Avi Molcho (Co-founder (No longer with the company)).
What sector is Biolojic Design in?
Biolojic Design operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Digital Healthcare, Medical Decision Support, with core technologies in Biologicals, Molecules, Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.
Where is Biolojic Design located?
Biolojic Design is based in HaMada St 12, Rehovot, Israel, Center District. The company also has offices abroad.